Peters Kevin G, Kontos Christopher D, Lin P Charles, Wong Adrianne L, Rao Prema, Huang Liwen, Dewhirst Mark W, Sankar Sabita
Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, Ohio 45140, USA.
Recent Prog Horm Res. 2004;59:51-71. doi: 10.1210/rp.59.1.51.
Abundant data now demonstrate that the growth of new blood vessels, termed angiogenesis, plays both pathological and beneficial roles in human disease. Based on these data, a tremendous effort has been undertaken to understand the molecular mechanisms that drive blood vessel growth in adult tissues. Tie2 recently was identified as a receptor tyrosine kinase expressed principally on vascular endothelium. Disrupting Tie2 function in mice resulted in embryonic lethality with defects in embryonic vasculature, suggesting a role in blood vessel maturation and maintenance. Based on these studies, we undertook a series of studies to probe the function of Tie2 in adult vasculature that will form the focus of this chapter. Consistent with a role in blood vessel growth in adult vasculature, Tie2 was upregulated and activated in the endothelium of rat ovary and in healing rat skin wounds, both areas of active angiogenesis. Moreover, Tie2 was upregulated in the endothelium of vascular "hot spots" in human breast cancer specimens. Surprisingly, Tie2 also was expressed and activated in the endothelium of all normal rat tissues examined, suggesting a role in maintenance of adult vasculature. To determine the functional role of Tie2 in tumor vasculature, a soluble Tie2 extracellular domain (ExTek) was designed that blocked the activation of Tie2 by its activating ligand, angiopoietin 1 (Ang1). Administration of recombinant ExTek protein or an ExTek adenovirus inhibited tumor growth and metastasis in rodent tumor models, demonstrating a functional role for Tie2 in pathological angiogenesis in adult tissues. To begin to understand the endothelial signaling pathways and cellular responses that mediate Tie2 function, we identified signaling molecules that are recruited to the activated, autophosphorylated Tie2 kinase domain. Two of these molecules, SHP2 and GRB2, are part of the pathway upstream of mitogen-activated protein kinase (MAPK) activation, a pathway that may be responsible for morphogenetic effects of Tie2 on endothelial cells. Another signaling molecule, p85, is responsible for recruitment of phosphatidylinositol 3 kinase (PI3-K) and activation of the Akt/PI3-K pathway. Akt/PI3-K has emerged as a critical pathway downstream of Tie2 that is necessary for cell survival effects as well as for chemotaxis, activation of endothelial nitric oxide synthase, and perhaps for anti-inflammatory effects of Tie2 activation. Taken together, these studies and many others demonstrate that the Tie2 pathway has important functions in adult tissues, in both quiescent vasculature and during angiogenesis, and help to validate the Tie2 pathway as a therapeutic target.
现在大量数据表明,新血管的生长,即血管生成,在人类疾病中既发挥病理作用,也发挥有益作用。基于这些数据,人们付出了巨大努力来了解驱动成体组织血管生长的分子机制。Tie2最近被鉴定为主要在血管内皮细胞上表达的一种受体酪氨酸激酶。破坏小鼠体内的Tie2功能会导致胚胎致死,并伴有胚胎血管系统缺陷,这表明Tie2在血管成熟和维持中发挥作用。基于这些研究,我们开展了一系列研究来探究Tie2在成体血管系统中的功能,这将构成本章的重点。与Tie2在成体血管系统血管生长中的作用一致,在大鼠卵巢内皮细胞以及愈合中的大鼠皮肤伤口(这两个都是活跃血管生成的区域)中,Tie2表达上调且被激活。此外,在人类乳腺癌标本的血管“热点”内皮细胞中,Tie2也上调。令人惊讶的是,在所有检测的正常大鼠组织的内皮细胞中,Tie2也有表达且被激活,这表明Tie2在维持成体血管系统中发挥作用。为了确定Tie2在肿瘤血管系统中的功能作用,设计了一种可溶性Tie2细胞外结构域(ExTek),它能阻断其激活配体血管生成素1(Ang1)对Tie2的激活。给予重组ExTek蛋白或ExTek腺病毒可抑制啮齿动物肿瘤模型中的肿瘤生长和转移,这证明了Tie2在成体组织病理性血管生成中发挥功能作用。为了开始了解介导Tie2功能的内皮信号通路和细胞反应,我们鉴定了被招募到激活的、自身磷酸化的Tie2激酶结构域的信号分子。其中两个分子,SHP2和GRB2,是有丝分裂原激活蛋白激酶(MAPK)激活上游通路的一部分,该通路可能负责Tie2对内皮细胞的形态发生作用。另一个信号分子p85负责募集磷脂酰肌醇3激酶(PI3-K)并激活Akt/PI3-K通路。Akt/PI3-K已成为Tie2下游的关键通路,对于细胞存活效应以及趋化作用、内皮型一氧化氮合酶的激活,或许还有Tie2激活的抗炎作用都是必需的。综上所述,这些研究以及许多其他研究表明,Tie2通路在成体组织中,在静止血管系统以及血管生成过程中都具有重要功能,并有助于验证Tie2通路作为一个治疗靶点的合理性。